162
Participants
Start Date
March 19, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2028
TPC induction chemotherapy
TPC induction chemotherapy regimen contains Polymeric micellar paclitaxel, which is a novel Cremophor EL-free, nanoparticle micellar formulation of paclitaxel, cisplatin and capecitabine. TPC induction chemotherapy regimen (polymeric micellar paclitaxel 200 mg/m2 D1, cisplatin 75 mg/m2 D1, capecitabine 1000 mg/m2/day D1-14, every 3 weeks for 3 cycles).
GP induction chemotherapy
GP induction chemotherapy regimen (gemcitabine 1000 mg/m2 D1/8, cisplatin 80 mg/m2 D1, every 3 weeks for 3 cycles)
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
NOT_YET_RECRUITING
Affiliated cancer hospital and institute of guangzhou medical university, Guangzhou
NOT_YET_RECRUITING
Sun Yat-Sen Memorial Hospital, Guangzhou
NOT_YET_RECRUITING
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
NOT_YET_RECRUITING
Dongguan people's hospital, Dongguan
NOT_YET_RECRUITING
Foshan First People's Hospital, Foshan
RECRUITING
Peking university shenzhen hospital, Shenzhen
RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Sun Yat-sen University
OTHER